News & Updation
Best Paper Awards
World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.
Best Article of current issue
Download Article : Click here
ANALYSIS OF DYSLIPIDAEMIC PATTERN OF INDIAN TYPE 2 DIABETES INDIVIDUALS USING AMERICAN DIABETES ASSOCIATION GUIDELINES
R. Anil Kumar*
Aims and Objectives-To analyse the lipid parameters of type 2 diabetes individuals not on any anti lipid drugs using American diabetes association guidelines. Methods --200 type 2 diabetes individuals attending out-patient department of Karnataka institute of endocrinology and research were randomly selected. They should not be taking any anti lipid medications. Fasting plasma glucose, post prandial plasma glucose, HBA1c, lipid profile, BMI, waist circumference and BP of these subjects were measured. Results- Diabetes subjects were in the age range of 20 to 70 years and 67.5% were males. The duration of diabetes was between new to 20 years. Family history was positive in 47% of the subjects. Hypertension was present in 37% of the subjects. LDL was <100, 100-129, 130-159, 160-189 and >190mg/dl were present in 23%, 34%, 20%, 9% and 2% of the diabetes subjects. HDL was less than 40 mg/dl in 67%, 40 to 60 mg/dl in 32.5% and more than 60 mg/dl in 0.5% of the diabetes subjects. Triglycerides were <150, 150-199, 200-499 and more than 500 mg/dl in 40%, 21.5%, 31.5% and 7% of the diabetes subjects. So the LDL and Triglyceride targets were achieved in 23%, 40% of the individuals respectively. HDL levels of 45 mg/dl in men and 55 mg/dl in women were achieved in only 12.6% and 7.7% respectively. Conclusions- The proportion of type 2 diabetes patients with lipid levels outside of clinical target values was high. Patients with established dyslipidaemia will require advice regarding diet, exercise and improvement in glycaemic control. This study suggests that an active strategy of early detection and drug treatment for dyslipidaemia is needed for 80 to 90% of type 2 diabetic patients.[Full Text Article]